|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Guardant Health, Inc. (GH) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
121,380,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Guardant Health is a precision oncology company focused on helping conquer cancer globally through use of its proprietary blood-based tests, data sets and analytics. Co. is engaged in the clinical liquid biopsy market with its Guardant360 and GuardantOMNI tests. Co.'s Guardant360 test is a molecular diagnostic test measuring a number of cancer-related genes and its GuardantOMNI test has a 500-gene panel, both of which analyze circulating tumor DNA in blood. In addition, Co. is developing tests from its LUNAR-1 program for minimal residual disease and recurrence detection in cancer survivors, and its LUNAR-2 program for early detection of cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
2,187 |
2,187 |
5,168 |
98,220 |
| Total Buy Value |
$38,963 |
$38,963 |
$136,461 |
$2,585,297 |
| Total People Bought |
1 |
1 |
1 |
2 |
| Total Buy Transactions |
1 |
1 |
2 |
4 |
| Total Shares Sold |
100 |
6,000 |
10,991 |
31,616 |
| Total Sell Value |
$1,905 |
$157,493 |
$334,111 |
$1,291,105 |
| Total People Sold |
1 |
2 |
2 |
3 |
| Total Sell Transactions |
1 |
3 |
6 |
11 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Merrill Amelia |
SVP, People |
• – – |
2024-01-01 |
4 |
D |
$27.05 |
$5,356 |
D/D |
(198) |
27,382 |
|
- |
|
| Merrill Amelia |
SVP, People |
• – – |
2024-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
482 |
27,580 |
|
- |
|
| Freeman Chris |
Chief Commercial Officer |
• – – |
2024-01-01 |
4 |
D |
$27.05 |
$17,150 |
D/D |
(634) |
14,573 |
|
- |
|
| Freeman Chris |
Chief Commercial Officer |
• – – |
2024-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,928 |
15,207 |
|
- |
|
| Eagle Craig |
Chief Medical Officer |
• – – |
2024-01-01 |
4 |
D |
$27.05 |
$19,016 |
D/D |
(703) |
10,359 |
|
- |
|
| Eagle Craig |
Chief Medical Officer |
• – – |
2024-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,714 |
11,062 |
|
- |
|
| Kalia Kumud |
Chief Information Officer |
• – – |
2024-01-01 |
4 |
D |
$27.05 |
$17,826 |
D/D |
(659) |
6,874 |
|
- |
|
| Kalia Kumud |
Chief Information Officer |
• – – |
2024-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,607 |
7,533 |
|
- |
|
| Krognes Steve E. |
Director |
– • – |
2023-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
154 |
2,776 |
|
- |
|
| Bell Michael Brian |
Chief Financial Officer |
• – – |
2023-12-15 |
4 |
D |
$28.19 |
$12,037 |
D/D |
(427) |
9,697 |
|
- |
|
| Bell Michael Brian |
Chief Financial Officer |
• – – |
2023-12-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,233 |
10,124 |
|
- |
|
| Potter Myrtle S |
Director |
– • – |
2023-12-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
69 |
7,309 |
|
- |
|
| Joyce Meghan V. |
Director |
– • – |
2023-12-04 |
4 |
AS |
$26.34 |
$2,634 |
D/D |
(100) |
4,422 |
|
- |
|
| Joyce Meghan V. |
Director |
– • – |
2023-12-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
66 |
4,522 |
|
- |
|
| Chudova Darya |
Chief Technology Officer |
• – – |
2023-12-01 |
4 |
D |
$26.33 |
$2,870 |
D/D |
(109) |
27,889 |
|
- |
|
| Chudova Darya |
Chief Technology Officer |
• – – |
2023-12-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
315 |
27,998 |
|
- |
|
| Merrill Amelia |
SVP, People |
• – – |
2023-12-01 |
4 |
D |
$26.33 |
$1,448 |
D/D |
(55) |
27,098 |
|
- |
|
| Merrill Amelia |
SVP, People |
• – – |
2023-12-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
158 |
27,153 |
|
- |
|
| Kalia Kumud |
Chief Information Officer |
• – – |
2023-12-01 |
4 |
S |
$26.37 |
$152,954 |
D/D |
(5,800) |
5,926 |
|
- |
|
| Kalia Kumud |
Chief Information Officer |
• – – |
2023-12-01 |
4 |
D |
$26.33 |
$9,294 |
D/D |
(353) |
11,726 |
|
- |
|
| Kalia Kumud |
Chief Information Officer |
• – – |
2023-12-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
710 |
12,079 |
|
- |
|
| Saia John G. |
Chief Legal Officer |
• – – |
2023-12-01 |
4 |
D |
$26.33 |
$3,449 |
D/D |
(131) |
20,602 |
|
- |
|
| Saia John G. |
Chief Legal Officer |
• – – |
2023-12-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
263 |
20,733 |
|
- |
|
| Krognes Steve E. |
Director |
– • – |
2023-11-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
154 |
2,622 |
|
- |
|
| Chudova Darya |
Chief Technology Officer |
• – – |
2023-11-15 |
4 |
OE |
$8.80 |
$35,200 |
D/D |
4,000 |
27,683 |
|
- |
|
671 Records found
|
|
Page 3 of 27 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
